← Back to Search

Procedure

Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency (WIRE-IT Trial)

N/A
Waitlist Available
Led By Greg Marcus, MD, MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-60 minutes (summation of first transseptal and second transseptal times)
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing two ways of puncturing through a thin wall in the heart, to see which is better.

Eligible Conditions
  • Atrial Flutter
  • Atrial Fibrillation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-60 minutes (summation of first transseptal and second transseptal times)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-60 minutes (summation of first transseptal and second transseptal times) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time to Achieve First Transseptal Puncture
Secondary study objectives
Combined Transseptal Time
Complication Rates
Fluoroscopy Time
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Baylis Versacross RF wireExperimental Treatment1 Intervention
Device: Baylis Versacross radiofrequency wire
Group II: Baylis RF NeedleActive Control1 Intervention
Device: conventional Baylis radiofrequency needle
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Baylis Versacross RF wire
2020
N/A
~80

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,887,875 Total Patients Enrolled
1 Trials studying Atrial Flutter
Baylis Medical CompanyIndustry Sponsor
9 Previous Clinical Trials
705 Total Patients Enrolled
Greg Marcus, MD, MASPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
120 Total Patients Enrolled
~15 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top